Companies / STE vs EW
STE vs EW: STERIS and Edwards Lifesciences
STERIS (STE) reported $5.9B in revenue against a 13.2% net margin, while Edwards Lifesciences (EW) reported $6.1B at a 17.7% net margin, most recently.
| Metric | STE | EW |
|---|---|---|
| Revenue | $5.9B | $6.1B |
| Net Income | $0.8B | $1.1B |
| Gross Margin | 44.2% | 78.0% |
| Operating Margin | 18.6% | 20.8% |
| EPS (Diluted) | $7.93 | $1.83 |
| Free Cash Flow | $1.0B | $1.3B |
| Total Debt | $1.9B | $0.6B |
| P/E Ratio | 27.9× | 46.6× |
| P/B Ratio | 3.0× | 4.8× |
| Stock Price | $254.27 | $100.81 |
Free: last 5 years
| Fiscal year | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| STE Revenue | ••••• | ••••• | ••••• | ••••• | — | $4.2B | $4.5B | $5.1B | $5.5B |
| EW Revenue | ••••• | ••••• | ••••• | ••••• | $5.2B | $4.5B | $5.0B | $5.4B | $6.1B |